Form D — Qlaris Bio, Inc.
0001786717-25-000002 · filed Nov 17, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $5,641,600
- Reported amount sold
- $5,641,600
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Qlaris Bio, Inc.
- CIK
- 1786717
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 770 Legacy Place
Dedham, Massachusetts 02026 - Phone
- 917-217-7007
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Thurein Htoo · Executive OfficerDedham, Massachusetts Find on LinkedIn ↗
-
Andrew Danielson · DirectorRochester, Minnesota Find on LinkedIn ↗
-
Adrienne Graves · DirectorDedham, Massachusetts Find on LinkedIn ↗
-
Ronald M. Hunt · DirectorNew York, New York Find on LinkedIn ↗
-
Wende Hutton · DirectorMenlo Park, California Find on LinkedIn ↗
-
Barbara Wirostko · Executive OfficerDedham, Massachusetts Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗